Ushbu ish iqtibos qilgan ishlar

59 ta ish

Ish: Relationship between severe acute respiratory syndrome coronavirus 2 and diabetes mellitus (review)

1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

   Fei Zhou, Ting Yu, Ronghui Du +16

   MaqolaOAOchiq kirish202013 iqtibos

   ABIABI:AkademIndex/2026.other.042529

2. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

   Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder +10

   Maqola202010 iqtibos

   ABIABI:AkademIndex/2026.other.508188

3. Endothelial cell infection and endotheliitis in COVID-19

   Zsuzsanna Varga, Andreas J. Flammer, Peter Steiger +7

   Boshqa20209 iqtibos

   ABIABI:AkademIndex/2026.other.581199

4. Type 2 diabetes as an inflammatory disease

   Marc Y. Donath, Steven E. Shoelson

   Sharh maqola20115 iqtibos

   ABIABI:AkademIndex/2026.other.570547

5. The trinity of COVID-19: immunity, inflammation and intervention

   Matthew Zirui Tay, Chek Meng Poh, Laurent Rénia +2

   Sharh maqolaOAOchiq kirish20204 iqtibos

   ABIABI:AkademIndex/2026.other.204770

6. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

   Bruce W. Bode, Valerie Garrett, Jordan Messler +4

   Maqola20204 iqtibos

   ABIABI:AkademIndex/2026.other.581201

7. Neutrophil extracellular traps in COVID-19

   Yu Zuo, Srilakshmi Yalavarthi, Hui Shi +10

   MaqolaOAOchiq kirish20203 iqtibos

   ABIABI:AkademIndex/2026.other.210933

8. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

   Lei Fang, George Karakiulakis, Michael Roth

   BoshqaOAOchiq kirish20203 iqtibos

   ABIABI:AkademIndex/2026.other.219226

9. Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

   Jordana B. Cohen, Thomas C. Hanff, Preethi William +30

   MaqolaOAOchiq kirish20212 iqtibos

   ABIABI:AkademIndex/2026.other.225813

10. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

    Chi Zhang, Zhao Wu, Jiawen Li +2

    Maqola20202 iqtibos

    ABIABI:AkademIndex/2026.other.551572

11. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.581164

12. Diabetes is a risk factor for the progression and prognosis of <scp>COVID</scp>‐19

    Weina Guo, Mingyue Li, Yalan Dong +11

    Maqola20202 iqtibos

    ABIABI:AkademIndex/2026.other.581192

13. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

    Ning Tang, Huan Bai, Xing Chen +3

    Maqola20202 iqtibos

    ABIABI:AkademIndex/2026.other.581193

14. COVID-19, diabetes mellitus and ACE2: The conundrum

    Rimesh Pal, Anil Bhansali

    Boshqa20202 iqtibos

    ABIABI:AkademIndex/2026.other.581195

15. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.581203

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.581160

17. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.581161

18. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.581162

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.581163

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.581165

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.581166

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.581167

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.581168

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.581169

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.581170